Before you decide
Ashwagandha has a reputation for being universally gentle — an adaptogen you can layer into any stack without much thought. That framing undersells the real contraindication list. Before reaching for a bottle, three categories of people should pause and speak with a clinician first.
Thyroid conditions: Ashwagandha has documented thyroid-stimulating activity. Several small RCTs report modest increases in T3 and T4 alongside TSH suppression. If you have Hashimoto’s thyroiditis, Graves’ disease, or you’re on levothyroxine or methimazole, adding ashwagandha without monitoring your thyroid panel is genuinely risky — not theoretically risky. I’ve seen patients end up outside therapeutic range on their thyroid medication because they added an ashwagandha product without telling their prescribing physician. That conversation needs to happen first.
Autoimmune conditions on immunosuppressants: Withanolides — the active steroidal lactones in ashwagandha — have demonstrated immunomodulatory activity in preclinical work, with some studies showing upregulation of NK-cell activity and Th1 cytokine signaling. A 2021 review in Phytomedicine catalogued this immune-stimulating profile. If you’re on tacrolimus, mycophenolate, or biologic agents for rheumatoid arthritis, lupus, or inflammatory bowel disease, an immune-stimulating botanical is not something to self-prescribe.
Pregnancy: Traditional Ayurvedic texts actually list ashwagandha as an abortifacient at high doses. No modern RCT safety data exists for pregnant populations. Full stop — avoid during pregnancy.
Beyond specific contraindications, it’s worth asking what you’re hoping ashwagandha will solve. If your primary complaint is anxiety, fatigue, or poor sleep, rule out the common upstream causes first: subclinical hypothyroidism, iron-deficiency anemia, obstructive sleep apnea, and caffeine overconsumption all mimic the conditions ashwagandha is often used for. Addressing those first means you’re not layering a supplement on top of an unresolved root cause. If your anxiety is severe enough that it’s functionally impairing you — affecting your work, relationships, or ability to leave the house — the conversation is conventional psychiatric evaluation first, and adjunct botanical support second. See our guide on natural supplements for anxiety for context on where adaptogens fit in a broader anxiety protocol.
What the research actually shows
Ashwagandha (Withania somnifera) is probably the most well-studied adaptogen in the Western research literature at this point, which is both a compliment and a caveat. “Well-studied” means there are enough RCTs to run meta-analyses. It does not mean the effect sizes are large or that the population studied reflects you specifically.
Stress and perceived stress
The stress data is the strongest category. A 2023 systematic review and meta-analysis in Journal of Ethnopharmacology pooled 12 RCTs (n=1,002) and found statistically significant reductions in Perceived Stress Scale scores versus placebo, with a standardized mean difference of around −0.79. That’s a moderate effect size — meaningful, but not transformative. The trials ranged from 8 to 12 weeks and largely used KSM-66 or Sensoril extracts at 300–600 mg daily.
Mechanistically, the proposed pathway runs through the hypothalamic-pituitary-adrenal (HPA) axis. Withanolides appear to modulate CRH (corticotropin-releasing hormone) signaling at the hypothalamus while also showing affinity for GABA-A receptors, which may partly explain the anxiolytic effect observed clinically. Whether that receptor-level activity at the studied doses translates cleanly to the clinical stress reductions seen in trials is still being characterized — the animal pharmacology is cleaner than the human dose-response data.
Cortisol
Cortisol reduction is the most-cited benefit in supplement marketing, and the data here is real but should be contextualized. The landmark 2019 Chandrasekhar KSM-66 trial (n=58, 60 days, 300 mg twice daily) showed approximately 27% reduction in morning serum cortisol compared to placebo. Subsequent trials have replicated directional findings, though effect sizes vary. What matters for interpretation: most trial participants were adults with self-reported chronic stress — not elite athletes, not clinically diagnosed cortisol disorders. The cortisol supplement evidence landscape is generally weak outside ashwagandha; this is one of the more credible entries. That said, I’d caution against framing ashwagandha as a “cortisol blocker” — it appears to attenuate exaggerated cortisol stress responses rather than suppressing baseline cortisol across the board.
Anxiety
A 2021 meta-analysis in Medicine pooled 5 RCTs specifically examining anxiety outcomes and found significant improvement on Hamilton Anxiety Rating Scale (HAM-A) and similar measures. Effect sizes were moderate. Importantly, all trials excluded participants with diagnosed anxiety disorders — these were subclinical or stress-adjacent anxiety presentations. This distinction matters enormously for clinical application. Ashwagandha’s anxiolytic data does not license it as a substitute for evidence-based anxiety treatments (CBT, SSRIs, SNRIs) in diagnosed generalized anxiety disorder or panic disorder. See our broader review of stress relief supplements for how ashwagandha compares to other botanical options in this space.
Sleep
A 2020 RCT in PLOS ONE (n=150, 600 mg KSM-66, 12 weeks) found significant improvements in sleep onset latency, total sleep time, and sleep efficiency measured via actigraphy in adults with insomnia complaints. The effect on sleep onset latency was particularly notable — approximately 6-minute improvement versus placebo, which is clinically modest but statistically robust. The proposed mechanism involves triethylene glycol (a constituent of ashwagandha leaves, distinct from withanolides) with apparent sleep-promoting activity in animal models, plus indirect effects through cortisol normalization reducing hyperarousal. For context on how this compares to other botanical sleep aids, see our sleep supplement guide.
Testosterone and male reproductive function
This is where the evidence gets genuinely thinner. A 2022 systematic review identified 4 RCTs on testosterone in men, finding modest increases (approximately 10–22% versus baseline) in some trials, primarily in infertile men or men under chronic stress. The effect in healthy, normally-fertile men with baseline testosterone in normal range is much less convincing. Marketing claims for ashwagandha as a testosterone booster extrapolate well beyond this evidence base. The signal is real in specific populations; the extrapolation to every gym-going male is not.
Forms and dosing — traditional vs RCT
This is arguably the most important section for anyone actually making a purchasing decision, because the product you’ll find on Amazon bears only a loose relationship to the intervention tested in most trials.
Traditional Ayurvedic formulations use 3–6 grams per day of whole dried root powder, often prepared as a decoction with milk (ashwagandha ksheerapaka) or combined with ghee and honey. The phytochemical profile of whole root prepared this way — including fat-soluble withanolides extracted into ghee, water-soluble alkaloids extracted into the decoction base — is not the same intervention as a standardized hydroalcoholic extract capsule. This isn’t a knock on traditional preparation; it’s an acknowledgment that when a study uses 600 mg KSM-66, you can’t map that evidence directly onto a 1,000 mg whole root powder capsule from a bulk supplement supplier.
The three standardized extracts with the most trial data are:
- KSM-66 (Ixoreal Biomed): Full-spectrum root extract, standardized to ≥5% withanolides using a milk-based extraction process that the manufacturer claims mimics traditional preparation. Most anxiety, stress, and cortisol trials use this extract at 300–600 mg/day. If you’re referencing the stress/anxiety RCT literature, KSM-66 is the closest match.
- Sensoril (Natreon): Root-and-leaf extract, standardized to ≥10% withanolide glycosides + 32% oligosaccharides. Typically studied at 125–250 mg/day due to higher withanolide density. Has its own RCT base showing stress and cognitive effects. The root-plus-leaf sourcing gives Sensoril a different alkaloid profile than root-only extracts — not better or worse, but different.
- Shoden (Arjuna Natural): Standardized to 35% withanolide glycosides — the highest standardization level of any commercial extract. Studied at 240 mg/day. Fewer trials than KSM-66 but emerging data on testosterone and physical performance.
- Generic ashwagandha root powder (various): Typically standardized to 1.5–5% withanolides (or not standardized at all). Cheaper, but the lot-to-lot variability in active constituent content is substantial, and no major RCT has used a non-branded generic as the study intervention. You’re buying on hope that your supplier’s withanolide content matches what was tested.
The dose discrepancy between traditional Ayurveda (5g+ whole root daily) and modern RCT doses (240–600 mg standardized extract) is not a dosing error in modern research — it reflects the concentration differential. 600 mg of a 5% withanolide extract delivers roughly the same withanolide mass as several grams of whole root. Understanding this prevents both the mistake of taking “traditional doses” of a concentrated extract (which could overshoot) and the mistake of dismissing modern extract research as under-dosed relative to tradition. For a broader look at how ashwagandha fits into the adaptogen category, see our complete adaptogen guide.
Safety and the 2024–2026 hepatotoxicity discussion
Ashwagandha is broadly well-tolerated in clinical trials — gastrointestinal discomfort (nausea, loose stools) is the most commonly reported adverse effect, typically mild and dose-dependent. That “well tolerated” characterization in the RCT literature is accurate and shouldn’t be dismissed. However, a separate signal has been accumulating in case report literature and regulatory databases that deserves honest coverage.
Between 2020 and 2025, a series of case reports documented idiosyncratic drug-induced liver injury (DILI) associated with ashwagandha supplementation. A 2023 case series in American Journal of Case Reports described 5 patients with hepatocellular pattern liver injury following ashwagandha use, with liver enzyme normalization upon discontinuation in all cases. NIH LiverTox classifies ashwagandha under “Likelihood Score B” — meaning probable cause of clinically apparent liver injury, rare but documented.
To be precise about what the evidence does and does not show: there is no signal of hepatotoxicity in RCT trial populations at standard doses. The cases reported involve idiosyncratic reactions — unpredictable, likely immune-mediated responses that occur in a small subset of individuals regardless of dose. This pattern looks similar to the DILI profile of other botanicals (green tea extract, kava) where the supplement is safe in trials but carries a rare but real hepatotoxicity risk in clinical use at scale.
The practical implication: if you develop jaundice (yellowing of skin or eyes), right upper quadrant abdominal pain, or dark urine while taking ashwagandha, stop immediately and get liver function tests. Do not wait to see if the symptoms resolve. This is not a reason to avoid ashwagandha categorically, but it is a reason to pay attention to your body’s signals and not dismiss early warning signs as “detox.” If you’re already on medications with known hepatic metabolism (statins, certain antidepressants, azole antifungals), a baseline liver function panel before starting and at 3 months is a reasonable precaution worth discussing with your physician.
How to choose ashwagandha for your goal
Given the proliferation of ashwagandha products — there are now hundreds of SKUs on Amazon alone — a decision framework helps more than a “best of” list.
Match the extract to the evidence for your goal. For stress, anxiety, and cortisol reduction: the KSM-66 trial base is deepest. For sleep: KSM-66 at 600 mg has the most direct sleep-specific RCT data. For testosterone support (with appropriate expectations): Shoden at 240 mg has emerging data. For a budget-conscious general adaptogen protocol: Sensoril at 250 mg has a reasonable evidence base at a lower price point than KSM-66 products.
Require third-party testing. Look for NSF Certified for Sport, USP Verified, Informed Sport, or Informed Choice certifications, particularly if you’re subject to drug testing. Beyond banned substance screening, third-party testing also validates heavy metal and microbial content — ashwagandha root, as a root crop, has a documented history of lead contamination in low-quality supply chains.
Avoid proprietary blends that obscure dose. If a product lists “Adaptogen Blend 750 mg” containing ashwagandha plus five other herbs, you have no idea whether the ashwagandha content is at the studied dose or at a token amount. This is especially common in combination stress or testosterone products. Require labeled per-ingredient doses.
Be skeptical of “sprayed-on standardization.” Some manufacturers take low-grade root powder and spray withanolide isolates onto it to hit a standardization percentage on the label. This is not the same as a genuine full-spectrum extract. The tell is price — a genuine KSM-66 or Sensoril licensed extract costs manufacturers significantly more than generic root powder. Products claiming 5% withanolides at a price point well below market norms for named extracts warrant skepticism. Our Recommended Products section below lists vetted options across budget tiers — those selections reflect lot-tested products meeting the criteria above.
For comparisons across the anxiety supplement category more broadly, our natural anxiety supplement guide covers where ashwagandha ranks against L-theanine, magnesium glycinate, and other botanicals with RCT data. For the depression-adjacent fatigue and low-mood presentations where adaptogens are sometimes considered, see our depression supplement evidence review, which includes appropriate refer-out language for clinical depression.
FAQ
Does ashwagandha lower cortisol in healthy people with normal cortisol levels?
The honest answer is: probably less than it does in stressed populations with elevated cortisol. Most positive cortisol trials enrolled participants with self-reported chronic stress, and the mechanism appears to attenuate exaggerated HPA-axis responses rather than suppress normal baseline cortisol. If your cortisol is already in a healthy range, expect modest or negligible effects. The supplement is not a general cortisol suppressant — it appears to be more of a stress-response buffer.
Can I take ashwagandha daily long-term? Is there evidence on cycle breaks?
Most RCTs run 8–12 weeks, so long-term safety data (beyond one year) in humans is limited. A 2022 safety assessment of daily KSM-66 use found no concerning laboratory findings at 12 months. Traditional Ayurvedic practice often includes cycle breaks (e.g., 3 months on, 1 month off), though this isn’t specifically validated in modern trials. I generally suggest a 4-week break every 3 months as a reasonable precaution until longer safety data accumulates, and to reassess whether the supplement is still needed.
Does ashwagandha interact with thyroid medication?
Yes, potentially — and this is not a theoretical concern. Ashwagandha has thyroid-stimulating activity documented in both animal models and human trials. A 2019 RCT found significant increases in T3 and T4 after 8 weeks of supplementation. If you’re on levothyroxine for hypothyroidism, this effect could push you into a hyperthyroid range. If you’re on methimazole or propylthiouracil for hyperthyroidism, ashwagandha’s thyroid-stimulating activity directly opposes your medication’s mechanism. In either case: discuss with your prescribing physician before starting, and monitor thyroid function if you proceed.
Why does my ashwagandha make me feel groggy the next morning?
This is a real and underreported phenomenon, particularly with evening dosing at higher doses (600 mg+). The GABA-A receptor activity mentioned earlier appears dose-dependent, and some individuals experience residual sedation the following morning — similar in quality to a mild antihistamine hangover. Options: switch to morning dosing, reduce dose to 300 mg, or try a different extract (Sensoril at 125 mg delivers meaningful withanolide content at a dose less likely to produce residual sedation). If grogginess persists, this may not be the right adaptogen for your neurochemistry.
Is there a meaningful difference between Sensoril and KSM-66 for anxiety specifically?
Both have RCT evidence for anxiety-adjacent outcomes, but the trial populations and endpoints differ enough that a direct head-to-head comparison doesn’t exist. KSM-66 has more anxiety-specific trial data using validated scales (GAD-7, HAM-A). Sensoril’s trial base leans more toward perceived stress and cognitive performance. Mechanistically, the root-plus-leaf extraction in Sensoril yields a different withanolide glycoside profile than root-only KSM-66. My clinical heuristic: for anxiety as the primary complaint, KSM-66 at 300–600 mg has the more directly applicable evidence base. For stress-related cognitive fog alongside anxiety, Sensoril has interesting data worth considering.
Once you have picked a product, our companion app, StackMyMed, scans its label and tracks it alongside everything else you take, with timing and interaction checks built in.
The bottom line on ashwagandha
Ashwagandha occupies an unusual position in the supplement landscape: it’s an herb with genuine, replicated RCT evidence in specific standardized forms at specific doses, a well-characterized mechanism framework rooted in HPA-axis modulation and GABA-A receptor activity, a meaningful traditional use history that isn’t just marketing mythology — and a set of real contraindications and a low-frequency but serious hepatotoxicity signal that gets systematically underplayed in consumer-facing content.
The evidence supports its use as an adjunct for stress-buffering, modest cortisol attenuation in stressed populations, sleep quality, and possibly male reproductive function in specific subgroups. The evidence does not support using it as a primary treatment for anxiety disorders, depression, or hypothyroidism, or extrapolating the standardized extract trial data to cheap root powder products with no quality verification.
If you’re going to use ashwagandha, three practical next steps apply:
- Rule out thyroid dysfunction, sleep apnea, and iron deficiency before attributing your fatigue or anxiety to a cortisol problem that ashwagandha will solve.
- Choose a product with a named standardized extract (KSM-66, Sensoril, or Shoden), verified dose on label, and third-party testing certification — not the cheapest ashwagandha capsule on Amazon.
- Pay attention to liver warning signs during the first 3 months of use: jaundice, right upper quadrant pain, or dark urine warrant immediate discontinuation and a same-week clinical evaluation.
Reviewed by Jonathan Reynolds, ND, focused on botanical and naturopathic protocols.
As an Amazon Associate, UsefulVitamins.com earns from qualifying purchases at no extra cost to you.
